Colongan, Shawn Levi C.
HRN: 21-34-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
09/30/2025
10/07/2025
TOPICAL
1ml
QID
Oral Sores
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes